Global Tyrosine Protein Kinase BTK Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 128

Report ID: 5427

The global Tyrosine Protein Kinase BTK market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tyrosine Protein Kinase BTK market based on company, product type, end user and key regions.

This report studies the global market size of Tyrosine Protein Kinase BTK in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tyrosine Protein Kinase BTK in these regions.
This research report categorizes the global Tyrosine Protein Kinase BTK market by top players/brands, region, type and end user. This report also studies the global Tyrosine Protein Kinase BTK market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie Inc
ACEA Biosciences, Inc.
Advinus Therapeutics Ltd
ArQule, Inc.
BeiGene, Ltd.
Beijing Hanmi Pharmaceutical Co Ltd
Biogen Inc
Bristol-Myers Squibb Company
Celgene Corporation
CrystalGenomics, Inc.
Genentech, Inc.
Hanmi Pharmaceuticals, Co. Ltd.
LSK BioPartners, Inc.
Merck KGaA
Pharmacyclics, Inc.
Principia Biopharma Inc.
Redx Pharma Plc
Simcere Pharmaceutical Group
Sunesis Pharmaceuticals, Inc.

Market size by Product
BMS-986195
CG-026806
ARQ-531
M-7583
ONO-4059
Others
Market size by End User
Hospital
Clinic
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Tyrosine Protein Kinase BTK market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tyrosine Protein Kinase BTK market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tyrosine Protein Kinase BTK companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tyrosine Protein Kinase BTK submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Tyrosine Protein Kinase BTK are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tyrosine Protein Kinase BTK market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Tyrosine Protein Kinase BTK Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tyrosine Protein Kinase BTK Market Size Growth Rate by Product
1.4.2 BMS-986195
1.4.3 CG-026806
1.4.4 ARQ-531
1.4.5 M-7583
1.4.6 ONO-4059
1.4.7 Others
1.5 Market by End User
1.5.1 Global Tyrosine Protein Kinase BTK Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Tyrosine Protein Kinase BTK Market Size
2.1.1 Global Tyrosine Protein Kinase BTK Revenue 2014-2025
2.1.2 Global Tyrosine Protein Kinase BTK Sales 2014-2025
2.2 Tyrosine Protein Kinase BTK Growth Rate by Regions
2.2.1 Global Tyrosine Protein Kinase BTK Sales by Regions
2.2.2 Global Tyrosine Protein Kinase BTK Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Tyrosine Protein Kinase BTK Sales by Manufacturers
3.1.1 Tyrosine Protein Kinase BTK Sales by Manufacturers
3.1.2 Tyrosine Protein Kinase BTK Sales Market Share by Manufacturers
3.1.3 Global Tyrosine Protein Kinase BTK Market Concentration Ratio (CR5 and HHI)
3.2 Tyrosine Protein Kinase BTK Revenue by Manufacturers
3.2.1 Tyrosine Protein Kinase BTK Revenue by Manufacturers (2014-2019)
3.2.2 Tyrosine Protein Kinase BTK Revenue Share by Manufacturers (2014-2019)
3.3 Tyrosine Protein Kinase BTK Price by Manufacturers
3.4 Tyrosine Protein Kinase BTK Manufacturing Base Distribution, Product Types
3.4.1 Tyrosine Protein Kinase BTK Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tyrosine Protein Kinase BTK Product Type
3.4.3 Date of International Manufacturers Enter into Tyrosine Protein Kinase BTK Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Tyrosine Protein Kinase BTK Sales by Product
4.2 Global Tyrosine Protein Kinase BTK Revenue by Product
4.3 Tyrosine Protein Kinase BTK Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Tyrosine Protein Kinase BTK Breakdown Data by End User

6 North America
6.1 North America Tyrosine Protein Kinase BTK by Countries
6.1.1 North America Tyrosine Protein Kinase BTK Sales by Countries
6.1.2 North America Tyrosine Protein Kinase BTK Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tyrosine Protein Kinase BTK by Product
6.3 North America Tyrosine Protein Kinase BTK by End User

7 Europe
7.1 Europe Tyrosine Protein Kinase BTK by Countries
7.1.1 Europe Tyrosine Protein Kinase BTK Sales by Countries
7.1.2 Europe Tyrosine Protein Kinase BTK Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tyrosine Protein Kinase BTK by Product
7.3 Europe Tyrosine Protein Kinase BTK by End User

8 Asia Pacific
8.1 Asia Pacific Tyrosine Protein Kinase BTK by Countries
8.1.1 Asia Pacific Tyrosine Protein Kinase BTK Sales by Countries
8.1.2 Asia Pacific Tyrosine Protein Kinase BTK Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tyrosine Protein Kinase BTK by Product
8.3 Asia Pacific Tyrosine Protein Kinase BTK by End User

9 Central & South America
9.1 Central & South America Tyrosine Protein Kinase BTK by Countries
9.1.1 Central & South America Tyrosine Protein Kinase BTK Sales by Countries
9.1.2 Central & South America Tyrosine Protein Kinase BTK Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tyrosine Protein Kinase BTK by Product
9.3 Central & South America Tyrosine Protein Kinase BTK by End User

10 Middle East and Africa
10.1 Middle East and Africa Tyrosine Protein Kinase BTK by Countries
10.1.1 Middle East and Africa Tyrosine Protein Kinase BTK Sales by Countries
10.1.2 Middle East and Africa Tyrosine Protein Kinase BTK Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tyrosine Protein Kinase BTK by Product
10.3 Middle East and Africa Tyrosine Protein Kinase BTK by End User

11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 Company Business Overview
11.1.3 AbbVie Inc Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AbbVie Inc Tyrosine Protein Kinase BTK Products Offered
11.1.5 AbbVie Inc Recent Development
11.2 ACEA Biosciences, Inc.
11.2.1 ACEA Biosciences, Inc. Company Details
11.2.2 Company Business Overview
11.2.3 ACEA Biosciences, Inc. Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.2.4 ACEA Biosciences, Inc. Tyrosine Protein Kinase BTK Products Offered
11.2.5 ACEA Biosciences, Inc. Recent Development
11.3 Advinus Therapeutics Ltd
11.3.1 Advinus Therapeutics Ltd Company Details
11.3.2 Company Business Overview
11.3.3 Advinus Therapeutics Ltd Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Advinus Therapeutics Ltd Tyrosine Protein Kinase BTK Products Offered
11.3.5 Advinus Therapeutics Ltd Recent Development
11.4 ArQule, Inc.
11.4.1 ArQule, Inc. Company Details
11.4.2 Company Business Overview
11.4.3 ArQule, Inc. Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.4.4 ArQule, Inc. Tyrosine Protein Kinase BTK Products Offered
11.4.5 ArQule, Inc. Recent Development
11.5 BeiGene, Ltd.
11.5.1 BeiGene, Ltd. Company Details
11.5.2 Company Business Overview
11.5.3 BeiGene, Ltd. Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.5.4 BeiGene, Ltd. Tyrosine Protein Kinase BTK Products Offered
11.5.5 BeiGene, Ltd. Recent Development
11.6 Beijing Hanmi Pharmaceutical Co Ltd
11.6.1 Beijing Hanmi Pharmaceutical Co Ltd Company Details
11.6.2 Company Business Overview
11.6.3 Beijing Hanmi Pharmaceutical Co Ltd Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Beijing Hanmi Pharmaceutical Co Ltd Tyrosine Protein Kinase BTK Products Offered
11.6.5 Beijing Hanmi Pharmaceutical Co Ltd Recent Development
11.7 Biogen Inc
11.7.1 Biogen Inc Company Details
11.7.2 Company Business Overview
11.7.3 Biogen Inc Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Biogen Inc Tyrosine Protein Kinase BTK Products Offered
11.7.5 Biogen Inc Recent Development
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Details
11.8.2 Company Business Overview
11.8.3 Bristol-Myers Squibb Company Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Bristol-Myers Squibb Company Tyrosine Protein Kinase BTK Products Offered
11.8.5 Bristol-Myers Squibb Company Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Details
11.9.2 Company Business Overview
11.9.3 Celgene Corporation Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Celgene Corporation Tyrosine Protein Kinase BTK Products Offered
11.9.5 Celgene Corporation Recent Development
11.10 CrystalGenomics, Inc.
11.10.1 CrystalGenomics, Inc. Company Details
11.10.2 Company Business Overview
11.10.3 CrystalGenomics, Inc. Tyrosine Protein Kinase BTK Sales, Revenue and Gross Margin (2014-2019)
11.10.4 CrystalGenomics, Inc. Tyrosine Protein Kinase BTK Products Offered
11.10.5 CrystalGenomics, Inc. Recent Development
11.11 Genentech, Inc.
11.12 Hanmi Pharmaceuticals, Co. Ltd.
11.13 LSK BioPartners, Inc.
11.14 Merck KGaA
11.15 Pharmacyclics, Inc.
11.16 Principia Biopharma Inc.
11.17 Redx Pharma Plc
11.18 Simcere Pharmaceutical Group
11.19 Sunesis Pharmaceuticals, Inc.

12 Future Forecast
12.1 Tyrosine Protein Kinase BTK Market Forecast by Regions
12.1.1 Global Tyrosine Protein Kinase BTK Sales Forecast by Regions 2019-2025
12.1.2 Global Tyrosine Protein Kinase BTK Revenue Forecast by Regions 2019-2025
12.2 Tyrosine Protein Kinase BTK Market Forecast by Product
12.2.1 Global Tyrosine Protein Kinase BTK Sales Forecast by Product 2019-2025
12.2.2 Global Tyrosine Protein Kinase BTK Revenue Forecast by Product 2019-2025
12.3 Tyrosine Protein Kinase BTK Market Forecast by End User
12.4 North America Tyrosine Protein Kinase BTK Forecast
12.5 Europe Tyrosine Protein Kinase BTK Forecast
12.6 Asia Pacific Tyrosine Protein Kinase BTK Forecast
12.7 Central & South America Tyrosine Protein Kinase BTK Forecast
12.8 Middle East and Africa Tyrosine Protein Kinase BTK Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tyrosine Protein Kinase BTK Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer